Activated Partial Thromboplastin Time or Prothrombin Time Prolongation During Rivaroxaban Administration: Clinical Risk Factors and Outcomes Analysis. [PDF]
Yuan Y, Li X, Qiu F.
europepmc +1 more source
Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation. [PDF]
Gurumurthy G +4 more
europepmc +1 more source
FVIII inhibitors display FV-neutralizing activity in the prothrombin time assay. [PDF]
Arsiccio A, Beavis J, Raut S, Coxon CH.
europepmc +1 more source
Prothrombin Time in Dicoumarol Therapy [PDF]
openaire +2 more sources
Impact of Lupus Anticoagulant on INR Using Recombinant Prothrombin Time Reagent. [PDF]
Kamal F, Othman HR.
europepmc +1 more source
Prognostic Utility of Prothrombin Time-International Normalized Ratio, Interleukin-6, and High-Density Lipoprotein Levels in Patients With Severe Sepsis. [PDF]
Kurmana MK +4 more
europepmc +1 more source
Association between the total bilirubin to prothrombin time ratio index and diabetic retinopathy, nephropathy, peripheral neuropathy, and foot disease: a retrospective study and risk prediction model construction. [PDF]
Sun T, Li S, Liu J.
europepmc +1 more source
Transient shortening of activated partial thromboplastin time and prothrombin time associated with transient global amnesia. [PDF]
Dziubek D, Dziubek K, Stodolak M.
europepmc +1 more source
The Predictive Value of Nomogram Model Based on Neutrophil-to-Lymphocyte Ratio (NLR) and Prothrombin Time-International Normalized Ratio (PT-INR)-to-Albumin Ratio (PTAR) for Early Bacterial Intra-Abdominal Infection After Orthotopic Liver Transplantation. [PDF]
Peng HB +9 more
europepmc +1 more source
Prolonged Prothrombin Time due to Drug-Drug Interaction of Warfarin after the Change from Bosentan to Macitentan: A Case of Pharmacist Intervention in the Outpatient Clinic. [PDF]
Kurimura T +9 more
europepmc +1 more source

